UTHEALTH HOME ABOUT SBMI A-Z WEBMAIL INSIDE THE UNIVERSITY |
![]() |
|||||||
|
Fusion Protein:ADAM9-PROSC |
Fusion Protein Summary |
![]() |
Fusion partner gene information | Fusion gene name: ADAM9-PROSC | FusionPDB ID: 2025 | FusionGDB2.0 ID: 2025 | Hgene | Tgene | Gene symbol | ADAM9 | PROSC | Gene ID | 8754 | 11212 |
Gene name | ADAM metallopeptidase domain 9 | pyridoxal phosphate binding protein | |
Synonyms | CORD9|MCMP|MDC9|Mltng | EPVB6D|PROSC | |
Cytomap | 8p11.22 | 8p11.23 | |
Type of gene | protein-coding | protein-coding | |
Description | disintegrin and metalloproteinase domain-containing protein 9ADAM metallopeptidase domain 9 (meltrin gamma)cellular disintegrin-related proteincone rod dystrophy 9metalloprotease/disintegrin/cysteine-rich protein 9myeloma cell metalloproteinase | pyridoxal phosphate homeostasis proteinPLP homeostasis proteinproline synthase co-transcribed bacterial homolog proteinproline synthetase co-transcribed bacterial homolog protein | |
Modification date | 20200313 | 20200313 | |
UniProtAcc | Q13443 | . | |
Ensembl transtripts involved in fusion gene | ENST ids | ENST00000466936, ENST00000481513, ENST00000487273, ENST00000484143, | ENST00000328195, |
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0) | * DoF score | 27 X 19 X 12=6156 | 6 X 6 X 5=180 |
# samples | 31 | 7 | |
** MAII score | log2(31/6156*10)=-4.31165311105397 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(7/180*10)=-1.36257007938471 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context (manual curation of fusion genes in FusionPDB) | PubMed: ADAM9 [Title/Abstract] AND PROSC [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0) | ADAM9(38865502)-PROSC(37623044), # samples:3 | ||
Anticipated loss of major functional domain due to fusion event. | ADAM9-PROSC seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. ADAM9-PROSC seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | ADAM9 | GO:0000186 | activation of MAPKK activity | 17704059 |
Hgene | ADAM9 | GO:0006509 | membrane protein ectodomain proteolysis | 9920899 |
Hgene | ADAM9 | GO:0034612 | response to tumor necrosis factor | 11831872 |
Hgene | ADAM9 | GO:0050714 | positive regulation of protein secretion | 17704059 |
![]() * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
![]() |
![]() * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
![]() |
Top |
Fusion Gene Sample Information |
![]() |
![]() * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | BRCA | TCGA-WT-AB41-01A | ADAM9 | chr8 | 38865502 | - | PROSC | chr8 | 37623044 | + |
ChimerDB4 | BRCA | TCGA-WT-AB41-01A | ADAM9 | chr8 | 38865502 | + | PROSC | chr8 | 37623044 | + |
ChimerDB4 | BRCA | TCGA-WT-AB41 | ADAM9 | chr8 | 38865502 | + | PROSC | chr8 | 37623043 | + |
Top |
Fusion ORF Analysis |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000487273 | ADAM9 | chr8 | 38865502 | + | ENST00000328195 | PROSC | chr8 | 37623044 | + | 2663 | 273 | 78 | 1001 | 307 |
ENST00000466936 | ADAM9 | chr8 | 38865502 | + | ENST00000328195 | PROSC | chr8 | 37623044 | + | 2780 | 390 | 195 | 1118 | 307 |
ENST00000481513 | ADAM9 | chr8 | 38865502 | + | ENST00000328195 | PROSC | chr8 | 37623044 | + | 2663 | 273 | 78 | 1001 | 307 |
ENST00000487273 | ADAM9 | chr8 | 38865502 | + | ENST00000328195 | PROSC | chr8 | 37623043 | + | 2663 | 273 | 78 | 1001 | 307 |
ENST00000466936 | ADAM9 | chr8 | 38865502 | + | ENST00000328195 | PROSC | chr8 | 37623043 | + | 2780 | 390 | 195 | 1118 | 307 |
ENST00000481513 | ADAM9 | chr8 | 38865502 | + | ENST00000328195 | PROSC | chr8 | 37623043 | + | 2663 | 273 | 78 | 1001 | 307 |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000487273 | ENST00000328195 | ADAM9 | chr8 | 38865502 | + | PROSC | chr8 | 37623044 | + | 0.000511207 | 0.9994887 |
ENST00000466936 | ENST00000328195 | ADAM9 | chr8 | 38865502 | + | PROSC | chr8 | 37623044 | + | 0.000551602 | 0.99944836 |
ENST00000481513 | ENST00000328195 | ADAM9 | chr8 | 38865502 | + | PROSC | chr8 | 37623044 | + | 0.000511207 | 0.9994887 |
ENST00000487273 | ENST00000328195 | ADAM9 | chr8 | 38865502 | + | PROSC | chr8 | 37623043 | + | 0.000511207 | 0.9994887 |
ENST00000466936 | ENST00000328195 | ADAM9 | chr8 | 38865502 | + | PROSC | chr8 | 37623043 | + | 0.000551602 | 0.99944836 |
ENST00000481513 | ENST00000328195 | ADAM9 | chr8 | 38865502 | + | PROSC | chr8 | 37623043 | + | 0.000511207 | 0.9994887 |
Top |
Fusion Amino Acid Sequences |
![]() |
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP >2025_2025_1_ADAM9-PROSC_ADAM9_chr8_38865502_ENST00000466936_PROSC_chr8_37623043_ENST00000328195_length(amino acids)=307AA_BP=62 MGSGARFPSGTLRVRWLLLLGLVGPVLGAARPGFQQTSHLSSYEIITPWRLTRERREAPRPYSKQDLPAIQPRLVAVSKTKPADMVIEAY GHGQRTFGENYVQELLEKASNPKILSLCPEIKWHFIGHLQKQNVNKLMAVPNLFMLETVDSVKLADKVNSSWQRKGSPERLKVMVQINTS GEESKHGLPPSETIAIVEHINAKCPNLEFVGLMTIGSFGHDLSQGPNPDFQLLLSLREELCKKLNIPADQVELSMGMSADFQHAVEVGST -------------------------------------------------------------- >2025_2025_2_ADAM9-PROSC_ADAM9_chr8_38865502_ENST00000466936_PROSC_chr8_37623044_ENST00000328195_length(amino acids)=307AA_BP=62 MGSGARFPSGTLRVRWLLLLGLVGPVLGAARPGFQQTSHLSSYEIITPWRLTRERREAPRPYSKQDLPAIQPRLVAVSKTKPADMVIEAY GHGQRTFGENYVQELLEKASNPKILSLCPEIKWHFIGHLQKQNVNKLMAVPNLFMLETVDSVKLADKVNSSWQRKGSPERLKVMVQINTS GEESKHGLPPSETIAIVEHINAKCPNLEFVGLMTIGSFGHDLSQGPNPDFQLLLSLREELCKKLNIPADQVELSMGMSADFQHAVEVGST -------------------------------------------------------------- >2025_2025_3_ADAM9-PROSC_ADAM9_chr8_38865502_ENST00000481513_PROSC_chr8_37623043_ENST00000328195_length(amino acids)=307AA_BP=62 MGSGARFPSGTLRVRWLLLLGLVGPVLGAARPGFQQTSHLSSYEIITPWRLTRERREAPRPYSKQDLPAIQPRLVAVSKTKPADMVIEAY GHGQRTFGENYVQELLEKASNPKILSLCPEIKWHFIGHLQKQNVNKLMAVPNLFMLETVDSVKLADKVNSSWQRKGSPERLKVMVQINTS GEESKHGLPPSETIAIVEHINAKCPNLEFVGLMTIGSFGHDLSQGPNPDFQLLLSLREELCKKLNIPADQVELSMGMSADFQHAVEVGST -------------------------------------------------------------- >2025_2025_4_ADAM9-PROSC_ADAM9_chr8_38865502_ENST00000481513_PROSC_chr8_37623044_ENST00000328195_length(amino acids)=307AA_BP=62 MGSGARFPSGTLRVRWLLLLGLVGPVLGAARPGFQQTSHLSSYEIITPWRLTRERREAPRPYSKQDLPAIQPRLVAVSKTKPADMVIEAY GHGQRTFGENYVQELLEKASNPKILSLCPEIKWHFIGHLQKQNVNKLMAVPNLFMLETVDSVKLADKVNSSWQRKGSPERLKVMVQINTS GEESKHGLPPSETIAIVEHINAKCPNLEFVGLMTIGSFGHDLSQGPNPDFQLLLSLREELCKKLNIPADQVELSMGMSADFQHAVEVGST -------------------------------------------------------------- >2025_2025_5_ADAM9-PROSC_ADAM9_chr8_38865502_ENST00000487273_PROSC_chr8_37623043_ENST00000328195_length(amino acids)=307AA_BP=62 MGSGARFPSGTLRVRWLLLLGLVGPVLGAARPGFQQTSHLSSYEIITPWRLTRERREAPRPYSKQDLPAIQPRLVAVSKTKPADMVIEAY GHGQRTFGENYVQELLEKASNPKILSLCPEIKWHFIGHLQKQNVNKLMAVPNLFMLETVDSVKLADKVNSSWQRKGSPERLKVMVQINTS GEESKHGLPPSETIAIVEHINAKCPNLEFVGLMTIGSFGHDLSQGPNPDFQLLLSLREELCKKLNIPADQVELSMGMSADFQHAVEVGST -------------------------------------------------------------- >2025_2025_6_ADAM9-PROSC_ADAM9_chr8_38865502_ENST00000487273_PROSC_chr8_37623044_ENST00000328195_length(amino acids)=307AA_BP=62 MGSGARFPSGTLRVRWLLLLGLVGPVLGAARPGFQQTSHLSSYEIITPWRLTRERREAPRPYSKQDLPAIQPRLVAVSKTKPADMVIEAY GHGQRTFGENYVQELLEKASNPKILSLCPEIKWHFIGHLQKQNVNKLMAVPNLFMLETVDSVKLADKVNSSWQRKGSPERLKVMVQINTS GEESKHGLPPSETIAIVEHINAKCPNLEFVGLMTIGSFGHDLSQGPNPDFQLLLSLREELCKKLNIPADQVELSMGMSADFQHAVEVGST -------------------------------------------------------------- |
Top |
Fusion Protein Functional Features |
![]() Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr8:38865502/chr8:37623044) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
![]() |
![]() |
Hgene | Tgene |
ADAM9 | . |
FUNCTION: Cleaves and releases a number of molecules with important roles in tumorigenesis and angiogenesis, such as TEK, KDR, EPHB4, CD40, VCAM1 and CDH5. May mediate cell-cell, cell-matrix interactions and regulate the motility of cells via interactions with integrins. {ECO:0000250|UniProtKB:Q61072}.; FUNCTION: [Isoform 2]: May act as alpha-secretase for amyloid precursor protein (APP). {ECO:0000269|PubMed:12054541}. | FUNCTION: Might normally function as a transcriptional repressor. EWS-fusion-proteins (EFPS) may play a role in the tumorigenic process. They may disturb gene expression by mimicking, or interfering with the normal function of CTD-POLII within the transcription initiation complex. They may also contribute to an aberrant activation of the fusion protein target genes. |
![]() |
- Retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- Not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | ADAM9 | chr8:38865502 | chr8:37623043 | ENST00000487273 | + | 2 | 22 | 505_634 | 65.0 | 820.0 | Compositional bias | Note=Cys-rich |
Hgene | ADAM9 | chr8:38865502 | chr8:37623043 | ENST00000487273 | + | 2 | 22 | 790_795 | 65.0 | 820.0 | Compositional bias | Note=Poly-Pro |
Hgene | ADAM9 | chr8:38865502 | chr8:37623044 | ENST00000487273 | + | 2 | 22 | 505_634 | 65.0 | 820.0 | Compositional bias | Note=Cys-rich |
Hgene | ADAM9 | chr8:38865502 | chr8:37623044 | ENST00000487273 | + | 2 | 22 | 790_795 | 65.0 | 820.0 | Compositional bias | Note=Poly-Pro |
Hgene | ADAM9 | chr8:38865502 | chr8:37623043 | ENST00000487273 | + | 2 | 22 | 212_406 | 65.0 | 820.0 | Domain | Peptidase M12B |
Hgene | ADAM9 | chr8:38865502 | chr8:37623043 | ENST00000487273 | + | 2 | 22 | 414_501 | 65.0 | 820.0 | Domain | Disintegrin |
Hgene | ADAM9 | chr8:38865502 | chr8:37623043 | ENST00000487273 | + | 2 | 22 | 644_698 | 65.0 | 820.0 | Domain | EGF-like |
Hgene | ADAM9 | chr8:38865502 | chr8:37623044 | ENST00000487273 | + | 2 | 22 | 212_406 | 65.0 | 820.0 | Domain | Peptidase M12B |
Hgene | ADAM9 | chr8:38865502 | chr8:37623044 | ENST00000487273 | + | 2 | 22 | 414_501 | 65.0 | 820.0 | Domain | Disintegrin |
Hgene | ADAM9 | chr8:38865502 | chr8:37623044 | ENST00000487273 | + | 2 | 22 | 644_698 | 65.0 | 820.0 | Domain | EGF-like |
Hgene | ADAM9 | chr8:38865502 | chr8:37623043 | ENST00000487273 | + | 2 | 22 | 29_697 | 65.0 | 820.0 | Topological domain | Extracellular |
Hgene | ADAM9 | chr8:38865502 | chr8:37623043 | ENST00000487273 | + | 2 | 22 | 719_819 | 65.0 | 820.0 | Topological domain | Cytoplasmic |
Hgene | ADAM9 | chr8:38865502 | chr8:37623044 | ENST00000487273 | + | 2 | 22 | 29_697 | 65.0 | 820.0 | Topological domain | Extracellular |
Hgene | ADAM9 | chr8:38865502 | chr8:37623044 | ENST00000487273 | + | 2 | 22 | 719_819 | 65.0 | 820.0 | Topological domain | Cytoplasmic |
Hgene | ADAM9 | chr8:38865502 | chr8:37623043 | ENST00000487273 | + | 2 | 22 | 698_718 | 65.0 | 820.0 | Transmembrane | Helical |
Hgene | ADAM9 | chr8:38865502 | chr8:37623044 | ENST00000487273 | + | 2 | 22 | 698_718 | 65.0 | 820.0 | Transmembrane | Helical |
Top |
Fusion Protein-Protein Interaction |
![]() |
![]() |
Gene | PPI interactors |
![]() |
Gene | STRING network |
ADAM9 | |
PROSC |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs to ADAM9-PROSC |
![]() (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Drug | Source | PMID |
Top |
Related Diseases to ADAM9-PROSC |
![]() (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Disease | Source | PMID |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |